PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-8.16
Negative P/E while Healthcare median is -1.73. Seth Klarman would scrutinize path to profitability versus peers.
14.02
P/S exceeding 1.5x Healthcare median of 8.64. Jim Chanos would check for potential multiple compression risks.
0.47
P/B less than half the Healthcare median of 1.95. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-43.60
Negative FCF while Healthcare median P/FCF is -8.54. Seth Klarman would investigate cash flow improvement potential.
-46.42
Negative operating cash flow while Healthcare median P/OCF is -6.40. Seth Klarman would investigate operational improvement potential.
0.47
Fair value ratio less than half the Healthcare median of 1.98. Joel Greenblatt would investigate if this discount is justified.
-3.06%
Negative earnings while Healthcare median yield is -2.16%. Seth Klarman would investigate path to profitability.
-2.29%
Negative FCF while Healthcare median yield is -1.98%. Seth Klarman would investigate cash flow improvement potential.